NEW Selling losers for tax season? Check the wash-sale window first
Our free Wash Sale Calculator shows the first day you can buy back — and flags buys that would cancel your tax loss.
Check a trade »

PEN | NYSE

$319.12 -$2.85 | -0.89%
TREND SIGNAL:Signal available — unlock to view |2026-10-30

Next Earnings: Nov 04, 2026

Company Overview:

Market Cap: $12.61B
Trailing PE: N/A
FWD PE *: 54x
Payout Ratio (TTM): —
52-Week Range: $221.26 - $362.41

* Forward PE is based on street estimates.

7.7 Year PEN Performance Metrics:

Total Return (with DRIP): 119.3% (10.74% CAGR)
Total Return (no DRIP): 119.3% (10.74% CAGR)
Share Price: 119.3% (10.74% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $21,931
Total Return $ (with DRIP): $11,931
PEN Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
PEN Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
Build Custom Charts
PEN - Chart 1
PEN - Chart 2
PEN - Chart 3

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

PEN Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

PEN - Revenue
PEN Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - Earnings Per Share (EPS)
PEN EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - Net Income
🔓 See the full chart40% off right now · 7-day free trial
PEN Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
PEN EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
PEN Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
PEN Free Cash Flow / Share CAGR:1Y: -37.68%2Y: -28.79%5Y: -4.35%10Y: 0.00%
PEN - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
PEN Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
PEN Gross Profit CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
PEN Shares Outstanding CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
PEN Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
PEN Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - Expenses
🔓 See the full chart40% off right now · 7-day free trial
PEN Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
PEN - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
PEN - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
PEN - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
PEN - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
PEN - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
PEN - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
PEN Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
PEN Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

PEN - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
PEN Actual Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
PEN Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
PEN Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
PEN - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
PEN Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

PEN - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
PEN Net Profit Margin CAGR:1Y: -20.26%2Y: 2.52%5Y: 17.21%10Y: 0.00%
PEN - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
PEN Gross Profit Margin CAGR:1Y: 0.83%2Y: 1.34%5Y: 1.62%10Y: 0.69%
PEN - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
PEN Price to Earnings CAGR:1Y: 37.41%2Y: 8.21%5Y: -23.05%10Y: 0.00%
PEN - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
PEN Price To Sales Ratio CAGR:1Y: 9.57%2Y: 10.78%5Y: -9.84%10Y: -1.23%
PEN - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
PEN Return on Capital Employed CAGR:1Y: -8.67%2Y: 3.05%5Y: 22.56%10Y: 0.00%
PEN - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
PEN Return on Invested Capital CAGR:1Y: -21.73%2Y: 3.71%5Y: 14.99%10Y: 0.00%

Compare stocks side-by-side

Projected Future Returns & Dividends for PEN

Based on past 7.7-year performance, here are PEN growth metrics:

Share price CAGR of +10.74%
Dividend CAGR of +0%

Using PEN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

PEN (DRIP)PEN - No DRIP
Current Price$319.12$319.12
Start Shares31.3431.34
Start Value$10,000$10,000
  
After 10 years:
Final Share Count31.3431.34
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$319.12$319.12
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - PEN

NOTE: Above numbers are our estimate based on PEN's Dividend and Price CAGR over past 7.7 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

Penumbra, Inc. (PEN) had its IPO on 2015-09-18, and is traded on NYSE stock exchange.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

PEN website: https://www.penumbrainc.com


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF model unavailable for PEN — no fundamentals on file (ETFs and funds are not modelable).